Major market moves reflect shifting geopolitical and M&A landscapes. A potential U.S.-China trade truce is reshaping commodity and semiconductor sectors, while Novartis’s $12 billion acquisition signals biotech consolidation. Here’s what these movements mean for investors.
Economic Performance in a Challenging Quarter China’s economic landscape has demonstrated both resilience and vulnerability in the third quarter, with…
The Ghost Town at America’s Financial Helm Walking through the corridors of the U.S. Treasury during IMF week felt like…
The Trump administration is reportedly considering taking strategic stakes in rare earth companies and establishing price floors to counter China’s export restrictions. Treasury Secretary Scott Bessent characterized Beijing’s actions as a “global supply chain power grab” that requires coordinated response with allies.
The United States is reportedly considering taking more direct stakes in rare earth companies and other strategic sectors to counter China’s export restrictions, according to Treasury Secretary Scott Bessent. The administration’s potential move toward strategic investments represents a significant shift in industrial policy aimed at protecting national security interests.
